Oxycodone

Purdue Pharma, U.S. states agree to new opioid settlement

‘I surrender. Just please help me’: A son’s moving note to his parents underlines the pain of addiction

McKinsey is open to settlement regarding opioid work in the U.S. and Canada

Sacklers cited fear of OxyContin lawsuits before transferring US$10-billion from Purdue Pharma, documents show

Trudeau brushes aside questions about Barton’s McKinsey role and firm’s opioids work

Canadian envoy silent on his knowledge of McKinsey role in Purdue opioid sales

OxyContin maker Purdue Pharma pleads guilty in criminal case

Canada’s provinces have filed opioid-related claims totalling $67.4-billion in U.S. court

U.S. pursues nearly $13-billion of claims in Purdue Pharma opioid probes, sources say

U.S. pursues nearly $13-billion of penalties in Purdue Pharma opioid probes

Indigenous overdose deaths jumped drastically from January to May as COVID-19 crisis hit

Owners of OxyContin maker Purdue Pharma were paid more after company’s big fine for misleading marketing

Purdue Pharma asks court to halt all litigation against it in Canada amid U.S. lawsuits

Purdue Pharma, facing over 2000 opioid crisis lawsuits, files for bankruptcy protection

More states sue opioid maker alleging deceptive marketing

B.C. alleges 20 years of deception in opioid lawsuit

B.C. to sue opioid makers for health-care expenses of overdose crisis